Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: A report from the national cancer data base, 2004-2010

JAMA Surgery

Volumn 149, Issue 12, 2014, Pages 1296-1305

  Wilke, Lee G ^a   Czechura, Tomasz ^b   Wang, Chih ^b   Lapin, Brittany ^b   Liederbach, Erik ^b   Winchester, David P ^b   Yao, Katharine ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST CONSERVATION SURGERY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONSERVATIVE TREATMENT; FEMALE; HEALTH INSURANCE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; REOPERATION; TUMOR RECURRENCE; TUMOR VOLUME; ADOLESCENT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIAL; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDY; REGISTER; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; REGISTRIES; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84919608378     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.926     Document Type: Article

References (40)

1. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312(11): 665-673.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16): 1233-1241.
3. Esbona K, Li Z, Wilke LG. Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review. Ann Surg Oncol. 2012;19(10): 3236-3245.
4. McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307(5): 467-475.
5. MorrowM, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302(14): 1551-1556.
6. Heil J, Breitkreuz K, Golatta M, et al. Do reexcisions impair aesthetic outcome in breast conservation surgery? exploratory analysis of a prospective cohort study. Ann Surg Oncol. 2012;19 (2): 541-547.
7. Sabel MS, Jorns JM, Wu A, Myers J, Newman LA, Breslin TM. Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. Am J Surg. 2012;204(1): 66-77.
8. Coopey S, Smith BL, Hanson S, et al. The safety of multiple re-excisions after lumpectomy for breast cancer. Ann Surg Oncol. 2011;18(13): 3797-3801.
9. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3): 683-690.
10. Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
11. Percy CF, Jack A, Shanmugarathan S, Sobin L, Parkin DM, Whelan S. ICD-0: International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
12. Census regions and divisions of the United States. 2009. http://www.census.gov. Accessed December 30, 2013.
13. Lovrics PJ, Cornacchi SD, Farrokhyar F, et al. Technical factors, surgeon case volume and positive margin rates after breast conservation surgery for early-stage breast cancer. Can J Surg. 2010;53(5): 305-312.
14. Atkins J, Al Mushawah F, Appleton CM, et al. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J Surg Res. 2012;177(1): 109-115.
15. DillonMF, Hill AD, Quinn CM, McDermott EW, O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol. 2006;13(3): 333-339.
16. Jacobs L. Positive margins: the challenge continues for breast surgeons. Ann Surg Oncol. 2008;15(5): 1271-1272.
17. MorrowM, Katz SJ. The challenge of developing quality measures for breast cancer surgery. JAMA. 2012;307(5): 509-510.
18. Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, van Dam GM. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol. 2009;16(10): 2717-2730.
19. Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol. 2008;15(5): 1297-1303.
20. BrueningW, Fontanarosa J, Tipton K, Treadwell JR, Launders J, Schoelles K. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010;152(4): 238-246.
21. O'Sullivan MJ, Li T, Freedman G, MorrowM. The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery. Ann Surg Oncol. 2007;14(11): 3133-3140.
22. Aziz D, Rawlinson E, Narod SA, et al. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J. 2006;12(4): 331-337.
23. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16): 2158-2164.
24. Pleijhuis RG, Kwast AB, Jansen L, et al. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making. Breast. 2013;22(5): 773-779.
25. Taghian A, MohiuddinM, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005;241(4): 629-639.
26. Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast-conserving surgery? surgeon attitudes and correlates. Ann Surg Oncol. 2010;17(2): 558-563.
27. Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J AmColl Surg. 2009;209(5): 608-613.
28. Sarrazin D, LêM, Rouëssé J, et al. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less: the experience of the Institut Gustave-Roussy. Cancer. 1984;53(5): 1209-1213.
29. Veronesi U, Saccozzi R, Del VecchioM, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305(1): 6-11.
30. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer. 1990;26(6): 668-670.
31. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332(14): 907-911.
32. Blichert-Toft M, Rose C, Andersen JA, et al; Danish Breast Cancer Cooperative Group. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr. 1992;11(11): 19-25.
33. van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;11(11): 15-18.
34. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92 (14): 1143-1150.
35. Houssami N, Macaskill P, MarinovichML, et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer. 2010;46(18): 3219-3232.
36. Houssami N, Macaskill P, MarinovichML, MorrowM. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: ameta-analysis. Ann Surg Oncol. 2014;21 (3): 717-730.
37. Adams BJ, Zoon CK, Stevenson C, Chitnavis P, Wolfe L, Bear HD. The role of margin status and reexcision in local recurrence following breast conservation surgery. Ann Surg Oncol. 2013;20(7): 2250-2255.
38. Kaufmann M, MorrowM, von Minckwitz G, Harris JR; Biedenkopf Expert Panel Members. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer. 2010;116(5): 1184-1191.
39. Moran MS, Schnitt SJ, Giuliano AE, et al; Society of Surgical Oncology; American Society for Radiation Oncology. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014;32(14): 1507-1515.
40. Dunne C, Burke JP, MorrowM, KellMR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009;27(10): 1615-1620.